Mitigating the Effects of COVID-19 Pandemic on Antenatal Attendance in Kisumu County: Leveraging Technology and Point of Care Diagnostics to deliver Differentiated Care (DiffCov) and integrated suite of digital tools and artificial intelligence for antenatal pregnancy risk stratification in sub-Saharan Africa (DiffCov study) DiffCov was a targeted intervention project focused on sustaining and improving maternal health services during the COVID-19 disruptions in Kisumu County, Kenya

The DiffCov study piloted technology-driven, AI-supported differentiated antenatal care in Kisumu County to counter COVID-19 disruptions. By integrating point-of-care diagnostics and digital risk stratification tools,

The ARS study: Validation of Artificial Intelligence-Developed Maternal, Infant Health Insights and Cognitive Intelligence (MIHICTM) Scores for Antenatal Pregnancy Risk Stratification in Low Resource Settings is a validation-focused research project evaluating the performance of an AI-driven scoring system for early pregnancy risk assessment in resource-constrained environments, particularly in sub-Saharan Africa.

This study builds on AI-based tools designed to predict maternal, fetal, and infant health risks using integrated data insights. The MIHICTM (Maternal, Infant Health Insights and Cognitive Intelligence) score is a proprietary or developed algorithmic metric that stratifies pregnancies into risk categories

The Neurocognitive Study : Effect of Maternal Psychological Health and Malnutrition on Cognitive Function in Children at Jaramogi Oginga Odinga Teaching and Referral Hospital. The study was a research initiative examining the interplay between maternal mental health, child malnutrition, and neurocognitive development in young children attending Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) in Kisumu County, Kenya (2023).

The Neurocognitive Study at Jaramogi Oginga Odinga Teaching and Referral Hospital explored how maternal psychological health and child malnutrition affect cognitive development in young children. By examining these linked risk factors, the study aimed to inform integrated interventions for better neurodevelopmental outcomes in resource-constrained settings.

Tuberculosis (TB) remains a major cause of illness and death globally, particularly among People Living with HIV (PLHIV). PLHIV have up to a 30% lifetime risk of developing active TB compared to 5-10% in the general population. Tuberculosis Preventive Therapy (TPT) significantly reduces TB incidence and mortality among PLHIV. Traditionally, TPT involved six months of daily isoniazid (6H). However, this long duration has resulted in suboptimal uptake and completion in Kenya.

In 2018, the World Health Organization recommended shorter regimens, including 3HP (three months of weekly isoniazid and rifapentine). Kenya adopted 3HP in 2021. However, there was limited real-world data on how well this short-course regimen performs in routine program settings.

Excepteur sint occaecat cupidatat non proident sunt in culpa qui officia desunt mollit anim id est laborum. sed ut per spiciatis unde omnis natus error vitae Inventore veritatis quasi architebeatae vitae dicta sunt explicabo nemo enim ipsam voluptatem quia voluptassit.aspernatur aut odit aut fugit sed quia eos consequntur magni dolores eos qui ratione

Sequi nesciunt neque porro qusquam est qui dolore ipsum quia dolor sit amet consecteturadipisc velit sed quia non numquam eius modi.